Not enough black and brown people are signing up for Wuhan coronavirus (COVID-19) vaccine trials in the United Kingdom, which has prompted the UK Vaccines Taskforce to issue a plea for more “diversity” in its human guinea pig medical experiments.
Ever since it was reported by the mainstream media that ethnic minorities are supposedly more prone to developing complications from the Wuhan coronavirus (COVID-19) than people with white skin, UK authorities have been scrambling to find more minority “representation” in the country’s vaccine trials.
Existing Wuhan coronavirus (COVID-19) vaccine trials have already recruited some 100,000 participants, but more are soon on the way as the “experts” rove for more “high risk” candidates, including the elderly, the immuno-compromised, and people with darker skin.
“Protecting those at risk is the only way we will end this pandemic,” announced Kate Bingham, chair of the UK Vaccines Taskforce, about how the UK government is specifically seeking out people from black, Asian and minority ethnic backgrounds.
“Getting 100,000 volunteers on board is a great start but we need many more people from many different backgrounds that we can call on for future studies if we are to find a vaccine quickly to protect those who need it.”
Listen below as Mike Adams, the Health Ranger, unpacks how Big Pharma purposely destroyed the reputation of hydroxychloroquine as a means of obtaining emergency approval for upcoming Wuhan coronavirus (COVID-19) vaccines:
Had the government of the UK looked closer at the actual data, it would have come to the realization that Wuhan coronavirus (COVID-19) risk is more a factor of socioeconomic status and employment type than it is about skin color. But in the age of social justice warrior-ism, the bandwagon approach to “science” has become the norm.
Consequently, UK officials are now engaged in a desperate search for more non-whites to get jabbed with experimental chemicals that are being rushed to market as part of President Donald Trump’s “Operation Warp Speed” program to create fast-tracked vaccines for the entire world.
According to the Times of India, the British government is actually now putting out ads in Gujarati, Punjabi, and Bengali to try to attract more people of Indian descent to participate in Wuhan coronavirus (COVID-19) vaccine trials.
“Recruiting these groups might be more difficult now that English-language media in the US and the UK has been blasting out stories claiming minorities are more susceptible to the virus, when what they really mean is that minorities are dying at higher rates than white people largely because a higher percentage of minorities are in working-class jobs,” reports Zero Hedge.
“Given liberals’ fondness for justifying every wanton decision with ‘science,’ we’re curious about how this attitude evolved, considering that typically, racial differences don’t impact how a vaccine works in the human body.”
Ironically, this effort by the UK to recruit more minority human guinea pigs has the potential to slow the development of a workable Wuhan coronavirus (COVID-19) vaccine, which quite frankly will never come to fruition since vaccines are pseudoscience to begin with, especially when targeting viruses.
“I can’t imagine why anyone wouldn’t rush to sign up for a trial of an untested, rushed into production vaccine,” wrote one Zero Hedge commenter sarcastically.
“Big Pharma is rejoicing,” wrote another about how there is now “a world-wide laboratory of guinea pigs” on whom to test these deadly vaccine chemicals. “When the deadly concoction of chemicals fails, they can just blame it on the Covid1984,” this same commenter added.
For more related news about the Wuhan coronavirus (COVID-19) plandemic, be sure to check out Pandemic.news.
Sources for this article include:
Tagged Under: blacks, coronavirus, coronavirus vaccine, covid-19, depopulation, eugenics, experimentation, genocide, guinea pigs, medical experiments, minorities, side effects, UK, vaccine wars, vaccines
Vaccines.News is a fact-based public education website published by Vaccines News Features, LLC.
All content copyright © 2018 by Vaccines News Features, LLC.
All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.